Diabetes insipidus followed, after 4 years, with dysarthria and mild right‑ sided hemiparesis – the first clinical signs of Erdheim- Chester disease. Description and depiction of a case with a review of information on the disease
Authors:
Z. Adam 1; K. Balšíková 2; L. Pour 1; M. Krejčí 1; P. Svačina 2; M. Dufek 3; L. Křen 4; M. Hermanová 5; M. Moulis 4; J. Vaníček 6; J. Neubauer 7; M. Mechl 7; J. Prášek 8; J. Staníček 9; R. Koukalová 9; R. Hájek 1; J. Mayer 1
Authors‘ workplace:
Interní hematologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Jiří Vorlíček, CSc.
1; II. interní klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MU Dr. Miroslav Souček, CSc.
2; Neurologická klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MU Dr. Ivan Rektor, DrSc.
3; Ústav patologie Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MU Dr. Josef Feit, CSc.
4; Patologicko‑anatomický ústav Lékařské fakulty MU a FN u sv. Anny Brno, přednostka doc. MU Dr. Markéta Hermanová, Ph. D.
5; Klinika zobrazovacích metod Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MU Dr. Petr Krupa, CSc.
6; Radiodiagnostiká klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Vlastimil A. Válek, CSc.
7; Klinika nukleární medicíny Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MU Dr. Jiří Prášek, CSc.
8; Oddělení PET CT Masarykova onkologického ústavu Brno, přednosta prim. MU Dr. Karol Bolčák, Ph. D.
9
Published in:
Vnitř Lék 2009; 55(12): 1173-1188
Category:
Case Reports
Overview
In 2004, diabetes insipidus was the first clinical sign of Erdheim‑ Chester disease in our patient. Following introduction of substitution therapy with adiuretin, the patient had no further health complaints for four years until 2008 when he gradually developed dysarthria and, consequently, movement disorder in the form of mild right hemiparesis. The first CNS CT scan (2004) did not reveal any pathology. The first pathological MRI of the brain in 2006 – thickening of pituitary stalk by pathological infiltration to 4– 5 mm. During the following year, further infiltrates were detected in the CNS. The number and size of CNS infiltrates increased gradually on MRIs performed repeatedly up to 2008. Erdheim‑ Chester disease has become suspected based on PET‑CT examination at the end of 2008. CT showed irregular structure of the skeleton with noticeable sclerotic foci in otherwise osteoporotic bone structure; changes were the most evident in the long bones of lower limbs, in the pelvic bones, skull and arms, while only one vertebra was affected from within the entire spine. Finding of thickened aortic wall (up to 8 mm) as another pathological circumstance was consistent with the Erdheim‑ Chester disease‑associated changes described as coated aorta. CT scan revealed clear fibrotic changes in the area of retroperitoneum. Applied fluorodeoxyglucose has accumulated in the bone foci described on CT scans as well as in the thickened wall of the thoracic and abdominal aorta (SUV 3.6). Tc‑ pyrophosphonate skeleton scintigraphy showed the same bone foci as PET‑CT. Full body MRI showed pathological signal from the bone marrow of the above mentioned locations, particularly during STIR imagining, where there was clear abnormal signal corresponding to accumulated histiocytes, the higher signal of which was well‑differentiated from the normal bone marrow. Measurement of bone mineral density with DEXA confirmed reduced density in lumbar vertebrae to the average value of – 2.7 SD (the lowest value was – 3.1SD). The disease is associated with elevated inflammatory parameters: leucocytosis, thrombocytosis, elevated CRP and fibrinogen levels. Diagnosis was verified following histological assessment of iliac bone marrow, where focal infiltrations with foamy histiocytes of typical immunophenotype (CD68+, CD1a– , S100– ) were confirmed. Treatment was initiated with chemotherapy consisting of 2 g/ m2 of cyclophosphamide on day 1 and 200 mg/ m2 of etoposide IV infusion on days 1– 3, and followed by administration of 5 μg/ kg of G‑CSF and collection of haematopoietic peripheral blood stem cells (PBSC). PBSC collection was followed by 5‑ day administration of 5 mg/ m2/ day of 2‑ chlorodeoxyadenosine (Litac) administered to the patient at monthly intervals.
Key words:
Erdheim‑ Chester disease – juvenile xanthogranuloma – osteosclerosis – skeletal scinigraphy – PET‑CT – multiple myeloma – 2‑ chlorodeoxyadenosine – cladribin – retroperitoneal fibrosis
Sources
1. Mottl H, Koutecký J, Ganevová M. Strategie léčby histiocytózy z Langerhansových buněk u dětí. Čes Slov Pediat 1994; 49: 81.
2. Mottl H, Mracek J Kabelka Z et al. Histiocytóza z Langerhansových buněk u dětí. Čs Pediat 1992; 47: 530– 533.
3. Mottl H, Starý J. Histiocytóza z Langerhansových buněk u dětí – klinická diagnostika a současná léčba. Čes Pediatrie 2007; 62: 220– 225.
4. Ščudla V, Roček V, Dušek B et al. Multifokální eozinofilní granulom v dospělosti. Vnitř Lék 1987; 33: 1078– 1086.
5. Adam Z, Pour L, Krejčí M et al. Histiocytóza z Langerhansových buněk u osob dospělého věku – nemoc s mnoha tvářemi. Zkušenosti jednoho pracoviště a přehled projevů nemoci. Vnitř Lék 2008; 54: 1063– 1081.
6. Dickson BC, Pethe V, Chung CT et al. Systemic Erdheim- Chester disease. Virchows Arch 2008; 452: 221– 227.
7. Jendro MC, Zeidler H, Rosenthal H et al. Improvement of Erdheim‑ Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004; 23: 52– 56.
8. Lachenal F, Cotton F, Desmurs- Clavel Het al. Neurological manifestations and neuroradiological presentation of Erdheim‑Chester disease: report of 6 cases and systematic review of the literature. J Neurol 2006; 253: 1267– 1277.
9. Kinkor Z, Koudela K, Koudela K et al. Warfarinem vyvolaná hemorhagická pseudocysta malé pánve u ženy s vrozeným genetickým defektem koagulace komplikovaná usuračním pseudoxanthomem pánevní kosti napodobující Echeimovu Chesterovu nemoc. Acta Chir Ortop Traum Čechooslov 2007; 74: 114– 117.
10. Kinkor Z. Severe pulmonary involvement in Erdheim‑Chester disease (case report). Cesk Patol 2001; 37: 114– 117.
11. Kinkror Z. Závažné plicní postižení u Erheim- Chesterovy nemoci. Čes Slov Patol 2001; 37: 114– 117.
12. Kolár J, Kucera V, Povýsil C et al. Erdheim‑Chester disease. Rofo 1984; 141: 698– 701.
13. Mergancová J, Kubes L, Elleder M. Xanthogranulomatous processes in the area of the large vessels. Cesk Patol 1986; 22: 145– 150.
14. Mergancová J, Kubes L Elleder M. A xantogranulomatous process encircling large blood vessels (Erheim- Chester disease?). Czech Med 1988; 11: 57– 64.
15. Kučera V, Čáp V, Kužel J et al. Vzácná příčina osteosklerózy: Erheimův‑ Chesterův syndrome. ČS Radiol 1984; 38: 393– 402.
16. Janková H, Říhová E. Juvenilní xantogranulom. Oftalmologie v kasuistikách 2007; 3: 214– 218.
17. Vašáková M. Co je to Erheimova nemoc? Kazuist Alergol Pneumol ORL 2006; 3: 22– 25.
18. Chester W. Über lipoigranulomatóse. Virchows Arch 1930; 279: 561– 602.
19. Jaffe HL. Metabolic, degenerative and inflammatory disease of bones and joints. Philadelphia: PA Lea and Febiger 1972: 531– 541.
20. Miller RL, Sheeler LR, Bauer TW et al. EC diseae. Am J Med 1986; 80: 1230– 1236.
21. Alper MG, Zimmermann LE, Piana FG. Orbital manifestatitons of Erdheim‑Chester disease. Trans Am Ophthalmol Soc 1983; 81: 64– 85.
22. Garg T, Chander R, Gupta T et al. Erdheim‑Chester disease with cutaneous features in an Indian patient. Skinmed 2008; 7: 103– 106.
23. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003; 27: 579– 593.
24. Kenn W, Eck M, Allolio B et al. Erheim- Chester disease: evidence for disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immonohistochemical analysis. Hum Pathol 2000; 31: 734– 739.
25. Kenn W, Stäbler A, Zachoval R et al. Erdheim Chester disease: a case report and literature overview. Eur Radiol 1999; 9: 153– 158.
26. Veyssier- Belot C, Cacoub P, Caparros- Lefebvre B et al. Erdheim Chester disease: Clinical and radiological characteristics of 59 cases. Medicine (Baltimore) 1996; 75: 157– 169.
27. Swerdlow SH, Campo E, Harris NL et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press 2008.
28. Favara EB. Contemporary classification of histiocytis disorders. Med Pediatr Oncol 1997; 29: 157– 166.
29. Perras B, Petersen D, Lorch H et al. Psychoneuroendocrine disturbances in a patient with a rare granulomatous disease. Exp Clin Endocrinol Diabetes 2002; 110: 248– 252.
30. Brodkin CL, Wszolek ZK. Neurologic presentation of Erdheim‑Chester disease. Neurol Neurochir Pol 2006; 40: 397– 403.
31. De Abreu MR, Chung CB, Biswal S et al. Erdheim‑Chester disease: MR imaging, anatomic, and histopathologic correlation of orbital involvement. AJNR Am J Neuroradiol 2004; 25: 627– 630.
32. Salsano E, Savoiardo M, Nappini S et al. Late- onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim‑Chester disease. Neurol Sci 2008; 29: 263– 267.
33. Sistermann R, Katthagen BD. Erdheim Chester disease: a rare cause of knee and leg pain. Arch Orthop Trauma Surg 2000; 120: 112– 113.
34. Yanagi T, Kato N, Yamane N et al. Verruca plana‑like papules as a new manifestation of Erdheim‑Chester disease. Arch Dermatol 2007; 143: 952– 953.
35. Sivak‑ Callcott JA, Rootman J, Rasmussen SL et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol 2006; 90: 602– 608.
36. Watermann DF, Kiesewetter F, Frosch PJ. Skin manifestations of Erdheim‑Chester disease. Case report and review of the literature. Hautarzt 2001; 52: 510– 517.
37. Hammond MD, Niemi EW, Ward TP et al. Adult orbital xanthogranuloma with associated adult‑ onset asthma. Ophthal Plast Reconstr Surg 2004; 20: 329– 332.
38. Karcioglu ZA, Sharara N, Boles TL et al. Orbital xanthogranuloma: clinical and morphologic features in eight patients. Ophthal Plast Reconstr Surg 2003; 19: 372– 381.
39. Kujat C, Martin J, Püschel W. Erdheim‑Chester disease. Radiologe 1991; 31: 297– 306.
40. Fink MG, Levinson DJ, Brown NL et al. Erdheim‑Chester disease. Case report with autopsy finding. Arch Pathol Lab Med 1991; 21: 1714– 1716.
41. Tien RD, Brasch RC, Jackson DE et al. Cerebral Erdheim‑Chester disease: persistent enhancement with Gd‑ DTPA on MR images. Radiology 1989; 172: 791– 792.
42. Martinez R. Erdheim‑Chester disease: MR of intraaxial and extraaxial brain stem lesion. AJNR Am J Neuroradiol 1995; 16: 1787– 1790.
43. Ernemann U, Skalej M, Hermison M et al. Primary cerebral non Langerhans cell histiocytosis MR and diferential diagnosis. Neuroradiology 2002; 44: 759– 763.
44. Babu RP, Lansen TA, Chadburn A et al. Erdheim‑Chester disease of the central nervous system. Report of two cases. J Neurosurg 1997; 86: 888– 892.
45. Bohlega S, Alwatban J, Tulbah A et al. Cerebral manifestation of Erdheim‑Chester disease. Clinical and radiological findings. Neurology 1997; 49: 1702– 1705.
46. Weidauer S, von Stuckrad‑Barre S, Dettmann E et al. Cerebral Erdheim‑Chester disease: case report and review of the literature. Neuroradiology 2003; 45: 241– 245.
47. Wright RA, Hermann RC, Parisi JE. Neurological manifestation of Erdheim‑Chester disease. J Neurol Neurosurg Psychiatry 1999; 66: 72– 75.
48. Shimada S, Ono K, Hashizume Y et al. Intracranial lesion of Erdheim‑Chester disease. Hum Pathol 2007; 38: 950– 951.
49. Grothe C, Urbach H, Bös M et al. Cerebellar syndrome, exophthalmos and secondary hypogonadism in Erdheim‑Chester disease. Nervenarzt 2001; 72: 449– 452.
50. Khamseh ME, Mollanai S, Hashemi F et al. Erdheim‑Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002; 25: 727– 729.
51. Kovacs K, Bilbao JM, Fornasier VL et al. Pituitary pathology in Erdheim‑Chester disease. Endocr Pathol 2004; 15: 159– 166.
52. Oweity T, Scheithauer BW, Ching HS et al. Multiple system Erdheim‑Chester disease with massive hypothalamic‑ sellar involvement and hypopituitarism. J Neurosurg 2002; 96: 344– 351.
53. Tritos NA, Weinrib S, Kaye TB. Endocrine manifestations of Erdheim‑Chester disease (a distinct form of histiocytosis). J Intern Med 1998; 244: 529– 535.
54. Sheu SY, Wenzel RR, Kersting R et al. Erdheim‑Chester disease: A case report with multisystemic manifestation including testes, thyroid, and lymph nodes and review of literature. J Clin Pathol 2004; 57: 1225– 1228.
55. Bullmann C, Faust M, Hoffmann E et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol 2000; 142: 365– 372.
56. Mahnel R, Tan KH, Fahlbusch R et al. Problems in differential diagnosis of non Langerhans cell histiocytosis with pituitary involvement: case report and review of literature. Endocr Pathol 2002; 13: 361– 368.
57. Sheen KC, Chang CC, Chant TC et al. Thickened pituitary stalk with central diabetes insipidus. Report of 3 cases. J Formos Med Assoc 2001; 100: 198– 204.
58. Takao T, Asaba K, Tanaka H et al. A case of lymphocytic infundibuloneurohypophysitis hypophisitits schowing diabetes insipidus followed by anterior hypopituitarism associated with trombnasthenia. Endocr J 2000; 47: 285– 291.
59. Tashiro T, Sano T, Xu B et al. Spectrum of different types of hypophysitis. A clinicopathologic study hypophysitis in 31 cases. Endocr Pathol 2002; 13: 183– 185.
60. Mohn A, Fahlbusch R, Dörr HG. Panhypopituaitarism associated with diabetes insipidus in a girl with suprasellar arachnoid cyst. Horm Res 1999; 52: 35– 38.
61. Folkerth RD, Price DL jr, Schwartz M et al. Xanthomatous hypophysitis. Am J Surg Pathol 1998; 22: 736– 741.
62. Athanasou NA, Barbatis C. Erdheim‑Chester disease with epiphyseal and systemic disease. J Clin Pathol 1993; 46: 481– 482.
63. Augoustides JG, Szeto WY. Unmasked diabetes insipidus after pericardial drainage and biopsy for pericardial effusion in association with Erdheim‑Chester disease. J Thorac Cardiovasc Surg 2008; 136: 217– 218.
64. Rushing EJ, Kaplan KJ, Mena H et al. Erdheim‑Chester disease of the brain: cytological features and differential diagnosis of a challenging case. Diagn Cytopathol 2004; 31: 420– 422.
65. Reithmeier T, Trost HA, Wolf S. Xanthogranuloma of the Erdheim‑Chester type within the sellar region. A case report. Clin Neuropathol 2002; 21: 24– 28.
66. Allen TC, Chevez‑Barrios P, Shetlar DJ et al. Pulmonary and ophthalmic involvement with Erdheim‑Chester disease: a case report and review of the literature. Arch Pathol Lab Med 2004; 128: 1428– 1431.
67. Kambouchner M, Colby T, Domenge C et al. Erdheim‑Chester disease with prominent pulmonary involvement associated with eosinophillic granuloma of mandibular bone. Histopathology 1997; 30: 353– 358.
68. Krüger S, Krop C, Wibmer T et al. Erdheim‑chester disease: a rare cause of interstitial lung disease. Med Klin (Munich) 2006; 101: 573– 576.
69. Protopapadakis C, Antoniou KM, Nicholson AG et al. Erdheim‑Chester disease: pulmonary presentation in a case with advanced systemic involvement. Respiration 2009; 77: 337– 340.
70. Shamburek RD, Brewer HB jr, Gochuico BR et al. Erdheim‑Chester disease. A rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001; 321: 66– 75.
71. Rush WL, Andriko JA, Galateau- Salle F et al. Pulmonary pathology of Erdheim‑Chester disease. Mod Pathol 2000; 13: 747– 754.
72. Vasáková M, Fiala P, Kinkor Z. Erdheim‑Chester disease. A case report. Monaldi Arch Chest Dis 2001; 56: 115– 117.
73. Vaglio A, Corradi D, Maestri R et al. Pericarditis heralding Erdheim‑Chester disease. Circulation 2008; 118: e511– e512.
74. Serratrice J, Granel B, De Roux C et al. “Coated aorta” a new sign of Erdheim‑Chester disease. J Rheumatol 2000; 27: 1550– 1553.
75. Haroche J, Amoura Z, Dion E et al. Cardiovascular involvement, an overlooked feature of Erdheim‑Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) 2004; 83: 371– 392.
76. Bassou D, El Kharras A, Amezyane TT et al. Cardiac Erdheim‑Chester. Intern Med 2009; 48: 83– 84.
77. Dion E, Graef C, Haroche J et al. Imaging of thoracoabdominal involvement in Erdheim‑Chester disease. AJR Am J Roentgenol 2004; 183: 1253– 1260.
78. Granier M, Micheau A, Serre I. A rare cause of cardiac tumour: an Erdheim‑Chester disease with cardiac involvement co- existing with an intracerebral Langerhans cell histiocytosis. Eur Heart J 2008; 29: 1929– 1935.
79. Loeffler AG, Memoli VA. Myocardial involvement in Erdheim‑Chester disease. Arch Pathol Lab Med 2004; 128: 682– 685.
80. Kudo Y, Iguchi N, Sumiyoshi T et al. Dramatic change of Ga‑ 67 citrate uptake before and after corticosteroid therapy in a case of cardiac histiocytosis (Erdheim‑Chester disease). J Nucl Cardiol 2006; 13: 867– 869.
81. Loddenkemper K, Hoeyr B, Loddenkemper C et al. A case of Erdheim‑Chester disease initially mistaken for Ormond’s disease. Nat Clin Pract Rhematol 2008; 4: 50– 55.
82. Bangard C, Lotz J, Rosenthal H et al. Erdheim‑Chester disease versus multifocal fibrosis and Ormond‘s disease: a diagnostic dilemma. Clin Radiol 2004; 59: 1136– 1141.
83. Murray M, Marshall M, England E et al. Erdheim‑Chester disease. Clin Radiol 2001; 56: 481– 484.
84. Haroche J, Amoura Z, Touraine P et al. Bilateral adrenal infiltration in Erdheim‑Chester disease. Report of seven cases and literature review. J Clin Endocrinol Metab 2007; 92: 2007– 2012.
85. Pickhardt PJ, Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 2005; 25: 719– 730.
86. Scheer M, Hon M, Fruauff AA et al. Perinephric xanthogranulomatosis: CT diagnosis and confirmation by CT‑ guided percutaneous biopsy. Clin Imaging 2000; 24: 64– 67.
87. Surabhi VR, Menias C, Prasad SR et al. Neoplastic and non‑neoplastic proliferative disorders of the perirenal space: cross‑ sectional imaging findings. Radiographics 2008; 28: 1005– 1017.
88. Colin P, Ballereau C, Lambert M et al. Retroperitoneal infiltration as the first sign of Erdheim‑Chester disease. Int J Urol 2008; 15: 455– 456.
89. Moore FO, Berne JD, Fox AD. Mesenteric panniculitis and Erdheim‑Chester disease: xanthogranulomatous diseases confused with malignancy. J Am Coll Surg 2007; 204: 326– 327.
90. Droupy S, Attias, D, Eschwege P. Bilateral hydronephrosis in a patient with Erdheim Chester disease. J Urol 1999; 162: 2084– 2085.
91. O‘Rourke R, Wong DC, Fleming S et al. Erdheim‑Chester disease: a rare cause of acute renal failure. Australas Radiol 2007; 51: B48– B51.
92. Verdalles U, Goicoechea M, García de Vinuesa H et al. Erdheim‑Chester disease: a rare cause of renal failure. Nephrol Dial Transplant 2007; 22: 1776– 1777.
93. Wimpissinger TF, Schernthaner G, Feichtinger H et al. Compression of kidneys in Erdheim‑Chester disease of retroperitoneum: Open surgical approach. Urology 2005; 65: 798.
94. Gupta A, Aman K, Al‑ Babtain M et al. Multisystem Erdheim‑Chester disease; a unique presentation with liver and axial skeletal involvement. Br J Haematol 2007; 138: 280.
95. Canbaz F, Dabak N, Baris S et al. Erdheim‑Chester disease: 99mTc‑ MDP bone scan provides the diagnosis. Eur J Nucl Med Mol Imaging 2005; 32: 998.
96. Dion E, Graef C, Miquel A et al. Bone involvement in Erdheim‑Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 2006; 238: 632– 639.
97. Girszyn N, Arnaud L, Villain D et al. Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim‑Chester disease. Rev Med Interne 2007; 28: 770– 774.
98. Hoffmann EM, Müller– Forel W, Pitz S et al. Erdheim‑Chester disease: a case report. Graefes Arch Clin Exp Ophthalmol 2004; 242: 803– 807.
99. Gottlieb R, Chen A. MR findings of Erdheim‑Chester disease. J Comput Assist Tomogr 2002; 26: 257– 261.
100. Nakahara T, Suzuki T, Uno K et al. 18F- FDG positron emission tomographic imaging in Erdheim‑Chester disease with skeletal and extra- skeletal involvement. Leuk Lymphoma 2006; 47: 935– 937.
101. Namwongprom S, Núñez R, Kim EE et al. Tc- 99m MDP bone scintigraphy and positron emission tomography/ computed tomography (PET/ CT) imaging in Erdheim‑Chester disease. Clin Nucl Med 2007; 32: 35– 38.
102. Blum R, Seymour JF, Hicks RJ. Role of 18FDG positron emission tomography scanning in the management of histiocytosis. Leuk Lymphoma 2002; 43: 2155– 2157.
103. Palotás A, Bogáts G, Lázár M et al. Radiopharmaceutical diagnosis of Erdheim‑Chester‘s disease. Nucl Med Commun 2007; 28: 63– 65.
104. Spyridonidis TJ, Giannakenas C, Barla Pet al. Erdheim‑Chester disease: a rare syndrome with a characteristic bone scintigraphy pattern. Ann Nucl Med 2008; 22: 323– 326.
105. Zanglis A, Valsamaki P, Fountos G. Erdheim‑Chester disease: Symmetric uptake in the 99mTc‑ MDP bone scan. Hell J Nucl Med 2008; 11: 164– 167.
106. Kim EE, Romero JA. Erdheim Chester disease demonstrated with bone radiographs and scans. Clin Imaging 1997; 21: 328– 331.
107. Koziolek MJ, Kunze E, Müller A et al. Erdheim‑Chester disease. Dtsch Med Wonchenschr 2005; 132: 25– 28.
108. Matsui K, Nagata Y, Hiraoka M. Radiotherapy for Erdheim‑Chester disease. Int J Clin Oncol 2007; 12: 238– 241.
109. Perlat A, Decaux O, Sébillot M et al. Erdheim‑Chester disease with predominant mesenteric localization: Lack of efficacy of interferon alpha. Joint Bone Spine 2009; 76: 315– 317.
110. Vanichaniramol N, Kingpetch K, Buranasupkajorn P et al. Erdheim‑Chester disease. Intern Med 2008; 47: 1633– 1634.
111. Ono K, Oshiro M, Uemura K et al. Erdheim‑Chester disease: case report with imunohistochemical and biochemical examination. Hum Pathol 1996; 27: 91– 95.
112. Egan AJ, Boardman LA, Swensen SJ et al. Erdheim Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999; 23: 17– 26.
113. Kim NR, Ko YH, Choe EY et al. Erdheim Chester disease Extesive marrow necrosis: a case report and review of the literature. Intern J Surg Pathol 2001; 9: 73– 79.
114. Busemann C, Kallinich B, Schwesinger G et al. Erdheim‑Chester disease with hemophagocytosis. Ann Hematol 2007; 86: 847– 849.
115. Rao RN, Chang CC, Uysal N et al. Fulminant multisystem non‑langerhans cell histiocytic proliferation with hemophagocytosis: a variant form of Erdheim‑Chester disease. Arch Pathol Lab Med 2005; 129: e39– e43.
116. Lopez P, Estes ML. Immunohistochemical characterization of the histiocytes in sinus histiocytosis with massive lymphadenopathy. Analysis of an extranodal case. Hum Pathol 1989; 20: 711– 715.
117. Bonnetti F, Chilosi M, Menestrina Fet al. Immunohistological analysis of Rosai‑ Dorfman histiocytosis. A disease of S‑ 100 + CD1– histiocytes. Virchows Arch Apathol Anat Histopathol 1987; 411: 129– 135.
118. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai‑ Dorfman disease). Review of the entity. Semin Diagn Pathol 1990; 7: 19– 73.
119. Braiteh F, Boxrud C, Esmaeli B et al. Successful treatment of Erdheim‑Chester disease, a non‑Langerhans‑ cell histiocytosis, with interferon‑alpha. Blood 2005; 106: 2992– 2994.
120. Bourke SC, Nicholson AG, Gibson GJ. Erdheim‑Chester disease: pulmonary infiltration responding to cyclophosphamide and prednisolone. Thorax 2003; 58: 1004– 1005.
121. Haroche J, Amoura Z, Trad SG. Variability in the efficacy of interferon alpha in Erdheim Chester disease by patient and site of involvement results in eight patients. Arthritis Rheum 2006; 54: 3330– 3336.
122. Esmaeli B, Ahmadi A, Tang R et al. Interferon therapy for orbital infiltration secondary to Erdheim‑Chester disease. Am J Ophthalmol 2001; 132: 945– 947.
123. Myra C, Sloper L, Tighe PJ et al. Treatment of Erdheim‑Chester disease with cladribine: a rational approach. Br J Ophthalmol 2004; 88: 844– 847.
124. Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: two cases of orbital involvement. Eye (Lond). 2000; 14: 606–612.
125. Rajendra B, Duncan A, Parslew R et al. Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine. Pediatr Blood Cancer 2009; 52: 423– 415.
126. Mascalchi M, Nencini P, Nistri M et al. Failure of radiation therapy for brain involvement in Erdheim Chester disease. J Neurooncol 2002; 59: 169– 172.
127. Miller RC, Villà S, Kamer S et al. Palliative treatment of Erdheim‑Chester disease with radiotherapy: a Rare Cancer Network study. Radiother Oncol 2006; 80: 323– 326.
128. Haroche J, Amoura Z, Charlotte F et al. Imatinib mesylate for platelet‑ derived growth factor receptor‑beta‑positive Erdheim‑Chester histiocytosis. Blood 2008; 111: 5413– 5415.
129. Boissel N, Wechsler B, Leblond V. Treatment of refractory Erdheim‑Chester disease with double autologous hematopoietic stem‑ cell transplantation. Ann Intern Med 2001; 135: 844– 845.
130. Srikulmontree T, Massey HD, Roberts WN et al. Treatment of skeletal Erdheim‑Chester disease with zoledronic acid: case report and proposed mechanisms of action. Rheumatol Int 2007; 27: 303– 307.
131. Eyigör S, Kirazli Y, Memis A et al. Erdheim‑Chester disease: the effect of bisphosphonate treatment – a case report. Arch Phys Med Rehabil 2005; 86: 1053– 1057.
132. Mossetti G, Rendina D, Numis FG et al. Biochemical markers of bone turnover, serum levels of interleukin‑6/ interleukin‑6 soluble receptor and bisphosphonate treatment in Erdheim‑Chester disease. Clin Exp Rheumatol 2003; 21: 232– 236.
133. Yahng SA, Kang HH, Kim SK et al. Erdheim‑Chester disease with lung involvement mimicking pulmonary lymphangitic carcinomatosis. Am J Med Sci 2009; 337: 302– 304.
134. de Abreu MR, Castro MO, Chung C et al. Erdheim‑Chester disease: case report with unique postmortem magnetic resonance imaging, high‑resolution radiography, and pathologic correlation. Clin Imaging 2009; 33: 150– 153.
135. Salsano E, Savoiardo M, Nappini S et al. Late‑ onset sporadic ataxia, pontine lesion, and retroperitoneal fibrosis: a case of Erdheim‑Chester disease. Neurol Sci 2008; 29: 263– 367.
136. Monfredi O, Jones C, Warnock N. No way in & no way out: a case of renal failure due to both pre‑ and post‑renal obstruction. Nephrol Dial Transplant 2008; 23: 2406– 2408.
137. Lin E. FDG PET/ CT for biopsy guidance in Erdheim‑Chester disease. Clin Nucl Med 2007; 32: 860– 862.
138. Yanagi T, Kato N, Yamane N et al. Verruca plana‑like papules as a new manifestation of Erdheim‑Chester disease. Arch Dermatol 2007; 143: 952– 953.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2009 Issue 12
Most read in this issue
- Pre‑eclampsia from the perspective of inter- professional collaboration
- The programme of managed ambulatory rehabilitation for patients after heart valve defect surgery
- The complexity of interactions of the tumour growth process
- Symmetrical phlebothrombosis of lower extremities resulting from congenital malformation of vena cava inferior